ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,446.00
2.17%
다우존스 지수
38,675.68
1.18%
Bitcoin
64,099.05
0.16%
Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Protara Therapeutics Inc (TARA)

  7. Protara Therapeutics Inc (TARA) 뉴스

TARA Protara Therapeutics Inc

2.91
0.02 (0.69%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Protara Therapeutics Inc TARA 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.02 0.69% 2.91 13:00:01
개장가 저가 고가 종가 전일 종가
2.91 2.835 2.99 2.91 2.89
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
02/05/202421:00GLOBEProtara Therapeutics Announces First Quarter 2024 Financial..
05/04/202421:04GLOBEProtara Therapeutics Announces Oversubscribed $45 Million..
05/04/202421:02GLOBEProtara Therapeutics Announces Alignment with FDA on..
05/04/202421:00GLOBEProtara Therapeutics Announces Positive Three-Month Data..
13/03/202421:00GLOBEProtara Therapeutics Announces Fourth Quarter and Full Year..
28/02/202422:00GLOBEProtara Therapeutics to Present at the TD Cowen 44th Annual..
24/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202406:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202406:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202322:30GLOBEProtara Therapeutics Announces Presentation of Additional..
15/11/202314:15EDGAR2Form EFFECT - Notice of Effectiveness
03/11/202321:31EDGAR2Form S-3 - Registration statement under Securities Act of..
03/11/202321:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202321:10EDGAR2Form 8-K - Current report
03/11/202321:00GLOBEProtara Therapeutics Announces Third Quarter 2023 Financial..
23/10/202321:00GLOBEProtara Therapeutics Announces Dosing of First Patient in..
20/09/202321:30GLOBEProtara Therapeutics Announces Dosing of First Patient in..
05/09/202320:30GLOBEProtara Therapeutics to Present at the H.C. Wainwright 25th..
03/08/202321:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/08/202321:12EDGAR2Form 8-K - Current report
03/08/202321:00GLOBEProtara Therapeutics Announces Second Quarter 2023 Financial..
19/07/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/07/202305:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/05/202321:00GLOBEProtara Therapeutics Announces Dosing of First Patients in..

최근 히스토리

NASDAQ
TARA
Protara Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유